Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
Federal judge grants pause to Pfizer, BioNTech in Covid-19 patent lawsuit trial brought by Moderna
Last year
Pharma
Eli Lilly loses case against Florida compounding pharmacy
Last year
Pharma
US sues Regeneron over ‘hundreds of millions’ in allegedly inflated Medicare reimbursements for Eylea
Last year
Pharma
Endo sues FDA over its handling of generic Adrenalin approvals
Last year
Pharma
FDA+
Judge offers early win for Arbutus as Moderna vaccine patent spat heats up
Last year
Pharma
Sanofi ends almost all state personal injury lawsuits over Zantac with undisclosed settlement
Last year
Pharma
Federal court gives Teva and Viatris another chance to invalidate J&J's last patent for Invega Sustenna
Last year
Pharma
EU's pharma legislative reforms 'will scare investment away,' Astellas executive says
Last year
Pharma
Liquidia wins against United Therapeutics in patent battle over PAH drug
Last year
Pharma
J&J can try again to dispute evidence in multidistrict talc litigation
Last year
Pharma
Ovid asks USPTO to review Marinus' patent around treatment of serious seizure condition
Last year
Pharma
SCOTUS raises questions over legal standing in abortion pill case
Last year
Pharma
FDA+
Nonprofit tracks surge in medication abortions as SCOTUS gears up for hearing
Last year
Pharma
Pharma companies question new EU incentives as revamp advances
Last year
Pharma
Appeals court reverses Novartis win over Regeneron in Eylea-Lucentis battle
Last year
Pharma
Federal appeals court rules in favor of Arkansas in PhRMA's suit over 340B expansion
Last year
Pharma
Other IRA cases could be influenced by New Jersey judge's decisions, expert says
Last year
Pharma
BeiGene files patent suits against Sandoz, MSN Group
Last year
Pharma
Updated: Pharma companies present IRA cases in New Jersey court
Last year
Pharma
Lawmakers call for 'line in the sand' between US and Chinese biotech companies
Last year
China
Pharma
Drugmakers gear up for joint IRA arguments as PhRMA appeals Texas verdict
Last year
Pharma
Sen. Warren attacks GSK's decision to shift inhaler from brand to authorized generic
Last year
Pharma
Republican senators join attack on Biden's proposal to seize drug patents based on price
Last year
Pharma
Drugmakers submit counteroffers as part of first round of drug price negotiations
Last year
First page
Previous page
10
11
12
13
14
15
16
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit